Skip to main content
Caplight Logo









Form Bio

Form Bio

Private
Austin, TexasHealthcare & Life Scienceshttps://www.formbio.com/

Last Round

Series A

Sep 27, 2022

Total Funding Raised

$30M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Form Bio is a biotechnology company that develops artificial intelligence-powered tools to enhance AAV gene therapy development through predictive modeling, automated candidate optimization, and virtual biomanufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

gene therapyAAVadeno-associated viruscomputational biologybioinformaticsdrug discoveryin silico drug discoverypredictive modelingvector optimizationbiotech softwareAI drug discoverydigital biologymanufacturing intelligencevertical SaaSlab-to-cloud

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Form Bio Comparables

Compare Form Bio with similar companies based on industry and business-model similarity.

Form Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LatchBio
78%
Watershed
74%
Betteromics
74%

Form Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 27, 2022

Key People

Founding team and executive leadership

Andrew Busey

Co-founder Co-CEO

Founding Team

Douglas Daniels

Chief Technology Officer

Executive Team

Linda Murray

Chief Financial Officer

Executive Team

Form Bio Investors

Notable investors and investment history

Form Bio investors
InvestorRounds
JAZZ Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 9, 2026

    Secured a multi-million dollar annual software services contract.

  • Aug 18, 2025

    Michelle Chen appointed President, CEO, and Board member.

Recent news

Latest coverage and updates

  • attends_eventSep 28, 2026

    Form Bio, Inc. attended event Cell & Gene Meeting on Sep 28th '26.

Form Bio Filings

Explore SEC and related filing metadata, where available.

Form Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Form Bio's valuation, stock price, and market status.

Is Form Bio a public or private company?

Form Bio is a private company.

What is the current stock price of Form Bio?

Form Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Form Bio worth (valuation)?

Valuation information for Form Bio is not publicly available.

Can I buy Form Bio stock?

Form Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Form Bio's last funding round?

Form Bio's most recent funding round was Series A on September 27, 2022.

Who are the main investors in Form Bio?

Key investors in Form Bio include JAZZ Venture Partners.

Will Form Bio IPO soon?

No public IPO plans have been announced for Form Bio.

How can I track Form Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Form Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range32
Year Founded2022
Last FundingSep 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?